AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $519,283 | -2.9% | 7,430 | -0.2% | 0.01% | 0.0% |
| Q2 2023 | $534,998 | +15.3% | 7,445 | -1.0% | 0.01% | +20.0% |
| Q1 2023 | $463,834 | -39.4% | 7,520 | -24.3% | 0.01% | -44.4% |
| Q4 2022 | $765,901 | +59.2% | 9,930 | -7.9% | 0.01% | +50.0% |
| Q3 2022 | $481,000 | -17.2% | 10,780 | -29.0% | 0.01% | -14.3% |
| Q2 2022 | $581,000 | -6.4% | 15,180 | +1.1% | 0.01% | 0.0% |
| Q1 2022 | $621,000 | +14.6% | 15,010 | +4.7% | 0.01% | +16.7% |
| Q4 2021 | $542,000 | +0.7% | 14,335 | -12.2% | 0.01% | 0.0% |
| Q3 2021 | $538,000 | -14.6% | 16,325 | +74.9% | 0.01% | -14.3% |
| Q2 2021 | $630,000 | +24.0% | 9,335 | +4.0% | 0.01% | +16.7% |
| Q1 2021 | $508,000 | -13.5% | 8,980 | +24.6% | 0.01% | -33.3% |
| Q4 2020 | $587,000 | +17.6% | 7,205 | +2.9% | 0.01% | 0.0% |
| Q3 2020 | $499,000 | +55.9% | 7,000 | +79.7% | 0.01% | +50.0% |
| Q2 2020 | $320,000 | -12.8% | 3,895 | +9.7% | 0.01% | 0.0% |
| Q4 2019 | $367,000 | – | 3,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |